AF in the exposed, % ((HR−1)/HR) | Men | Women |
Ever exposed cumulative exposure (mg/m3) | 1.4 (0.7–2.2) | 15.4 (9.4–21.0) |
Q1 0–0.27 | −2.1 (−7.0–2.6) | 15.1 (−7.0–32.5) |
Q2 0.27–0.62 | −3.6 (−8.2–0.9) | 6.9 (−19.5–27.5) |
Q3 0.62–1.54 | 2.9 (−1.1–6.6) | 29.4 (13.3–42.4) |
Q4 1.54+ | 6.1 (2.8–9.2) | 39.8 (21.1–54.1) |
Population attributable fraction % p* ((HR−1)/HR) | Men | Women |
Ever exposed | 0.4 (0.2–0.6) | 0.4 (0.2–0.5) |
Cumulative exposure (mg/m3) | ||
Q1 0–0.27 | −0.1 (−0.5–0.2) | 0.1 (−0.1–0.3) |
Q2 0.27–0.62 | −0.2 (−0.5–0.1) | 0.0 (−0.1–0.2) |
Q3 0.62–1.54 | 0.2 (−0.1–0.4) | 0.2 (0.1–0.3) |
Q4 1.54+ | 0.4 (0.2–0.6) | 0.1 (0.1–0.1) |
Results are presented for cumulative exposure (quartile 1–4).